Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

Bird flu vaccines face a problem: eggs

Fertilized hen eggs are still the main ingredient in making vaccines that may protect us against H5N1

Salon

Scientists are testing mRNA vaccines to protect cows and people against bird flu

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to the shots deployed during the COVID-19 pandemic

The Independent UK

Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK

The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Is This Biotech Stock's OpenAI Partnership a Game-Changer?

With AI making waves in biotech, could this biotech’s OpenAI partnership be the catalyst for new highs?

Barchart

The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive

Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.

Investors Business Daily

Option Trade On Volatile Moderna Stock Could Return 28% By Mid-July

This iron condor trade on Moderna stock has the potential to return 28% if the stock price stays between 118.90 and 181.10.

Investors Business Daily

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Axios

Read news from The Economist, FT, and more,
with one subscription

Moderna Tumbles After The FDA Throws A Curveball On Its Second Product

Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.

Investors Business Daily

Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views

Moderna stock broke out for the first time in a year Thursday after beating first-quarter expectations as its second potential approval looms.

Investors Business Daily

Coroner probes vaccine link to young woman's death

A Victorian coroner is investigating whether a woman's death from heart inflammation after receiving her third COVID-19 jab was due to the Moderna vaccine.

AAP

Dow Jones Climbs As Donald Trump Stock Dives; Cathie Wood Loads Up On This Amid 42% Plunge

The Dow Jones gained on the stock market today. A Donald Trump-linked entity fell while Cathie Wood bought a diving stock.

Investors Business Daily

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading.

StockNews.com

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications

The Guardian - UK

Stocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI Report

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed -0.37%. Stocks Monday traded mildly lower on a +2.3 bp rise in the 10-year T-note...

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna Nears Its First Breakout In Over A Year After Launching Third Cancer Vaccine Test

Moderna stock surged Monday, nearing its first breakout in over a year, after launching a third study of its cancer vaccine.

Investors Business Daily

Moderna Surges 14% After Covid Vaccine-Maker Surprises With Fourth-Quarter Profit

Moderna stock surged Thursday after the firm beat quarterly expectations, including turning around a surprise profit.

StockNews.com

Moderna (MRNA) Earnings Analysis: Buy or Watch for Gains?

Moderna’s (MRNA) mRNA platform is positioned to deliver significant long-term impact with its mRNA medicines, but declining sales amid plummeting demand for its COVID-19 vaccine, steep losses, and cash burn reflect uncertainty around its near-term prospects. As MRNA is set to release its fourth-quarter 2023 results this Thursday, let’s find…

StockNews.com

Moderna (MRNA) and Biogen (BIIB) - Are There Upsides Left in These Biotech Stocks?

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, adaptability, and technological advancements, demonstrating resilience. So, let’s analyze the upside potential of popular biotech stocks Biogen (BIIB) and Moderna (MRNA).

Get all your
news in one place.

100’s of premium titles.
One news app.

LiveScience

New mRNA 'cancer vaccine' trial launches in UK

The first U.K. patient has received a dose of "cancer vaccine" in a new trial.

StockNews.com

Moderna (MRNA) vs. Exelixis (EXEL) - Which Biotech Stock Is Worth Buying?

The biotech industry is poised for long-term growth, supported by the advancements in personalized medicine and integration with information technology. While leading biotech stocks Moderna (MRNA) and Exelixis (EXEL) should benefit from the industry tailwinds, let us predict which stock is worth buying.

The Guardian - UK

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology

Investors Business Daily

60% Of This Year's Top Stocks Are In This Sector (It's Not Tech)

Just when it looked like technology stocks took over the S&P 500 — another sector is on the rise.

Inverse

A Biochemist Reveals The One Tech That Could Revolutionize Drug Discovery

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

Top News

Moderna's COVID Vaccine Sales Exceed Expectations in 2023!

In a stunning achievement, Moderna recently announced that their preliminary COVID vaccine sales for 2023 have met their target. This is fantastic news for...

Investors Business Daily

11 Stocks Are Taking Off Already — And The Year Just Started

The calendar just flipped to 2024 — and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated.

1 … 7 8 9 10

People

Cathie Wood

684 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.